Clinical Trial Update: Platelet Response During the Second Cycle of Decitabine Can Predict Response and Survival for Myelodysplastic Syndrome

View source ↗

Summary

This clinical trial update reports that platelet response during the second cycle of decitabine may predict treatment response and survival in myelodysplastic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Samsung Medical Center | Conditions: Myelodysplastic Syndrome | Status: UNKNOWN